全文获取类型
收费全文 | 72938篇 |
免费 | 6055篇 |
国内免费 | 45篇 |
出版年
2023年 | 392篇 |
2022年 | 879篇 |
2021年 | 1579篇 |
2020年 | 1097篇 |
2019年 | 1235篇 |
2018年 | 1654篇 |
2017年 | 1370篇 |
2016年 | 2319篇 |
2015年 | 3428篇 |
2014年 | 3479篇 |
2013年 | 4265篇 |
2012年 | 5096篇 |
2011年 | 4666篇 |
2010年 | 2891篇 |
2009年 | 2670篇 |
2008年 | 3339篇 |
2007年 | 3299篇 |
2006年 | 2999篇 |
2005年 | 3219篇 |
2004年 | 3139篇 |
2003年 | 2614篇 |
2002年 | 2240篇 |
2001年 | 1605篇 |
2000年 | 1512篇 |
1999年 | 1383篇 |
1998年 | 704篇 |
1997年 | 649篇 |
1996年 | 691篇 |
1995年 | 536篇 |
1994年 | 540篇 |
1993年 | 496篇 |
1992年 | 989篇 |
1991年 | 885篇 |
1990年 | 819篇 |
1989年 | 824篇 |
1988年 | 800篇 |
1987年 | 721篇 |
1986年 | 677篇 |
1985年 | 663篇 |
1984年 | 622篇 |
1983年 | 471篇 |
1982年 | 363篇 |
1981年 | 357篇 |
1980年 | 340篇 |
1979年 | 468篇 |
1978年 | 380篇 |
1977年 | 313篇 |
1975年 | 308篇 |
1974年 | 323篇 |
1973年 | 315篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Sonia Coni Silvia Maria Serrao Zuleyha Nihan Yurtsever Laura Di Magno Rosa Bordone Camilla Bertani Valerio Licursi Zaira Ianniello Paola Infante Marta Moretti Marialaura Petroni Francesca Guerrieri Alessandro Fatica Alberto Macone Enrico De Smaele Lucia Di Marcotullio Giuseppe Giannini Marella Maroder Enzo Agostinelli Gianluca Canettieri 《Cell death & disease》2020,11(12)
92.
Martin T. R. Kuiper Marijke Holtrop Hans de Vries 《Molecular & general genetics : MGG》1988,213(2-3):519-528
93.
94.
95.
96.
I. Albesa P. Bogdanov A. Eraso N.R. Sperandeo M.M. de Bertorello 《Journal of applied microbiology》1995,78(4):373-377
I. ALBESA, P. BOGDANOV, A. ERASO, N.R. SPERANDEO AND M.M. DE BERTORELLO. 1995. The antibiotic activity of new synthetic isoxazolylnaphthoquinone imines was studied. Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922 were resistant to the four compounds studied (MIC > 128 µg ml−1 ), but Staphylococcus aureus ATCC 25923, ATCC 29213 and 30 clinical isolates of Staph. aureus were inhibited by 2-hydroxy- N -(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone-4-imine (I). This compound diminished bloodstream infection of mice injected i.m. with Staph. aureus; septicaemia decayed significantly when I was applied at the beginning of the infection while when I was given 3 d after bacterial challenge, a significant protection was afforded. Bactericidal activity in serum increased during the 5 h after I was administered i.p.
The acetyl derivative of I had a high MIC but when inoculated orally in mice decreased the Staph. aureus counts in circulation. This protection occurred only when the schedule of administration started close to the bacterial challenge. Antibiotic activity in vivo may be associated with in vitro effects. 相似文献
The acetyl derivative of I had a high MIC but when inoculated orally in mice decreased the Staph. aureus counts in circulation. This protection occurred only when the schedule of administration started close to the bacterial challenge. Antibiotic activity in vivo may be associated with in vitro effects. 相似文献
97.
98.
99.
Emily Olfson Catherine E. Cottrell Nicholas O. Davidson Christina A. Gurnett Jonathan W. Heusel Nathan O. Stitziel Li-Shiun Chen Sarah Hartz Rakesh Nagarajan Nancy L. Saccone Laura J. Bierut 《PloS one》2015,10(9)
The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations. 相似文献
100.